Evaluating the Safety and Immunogenicity of an Inactivated Swine-Origin H1N1 Influenza Vaccine in HIV-1 Infected Patients.
Phase of Trial: Phase IV
Latest Information Update: 14 Jul 2016
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- 16 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 May 2010 New trial record